• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

Akt1Akt2-IN-17

CAS No. 893422-47-4

Akt1Akt2-IN-17 ( Akt Inhibitor 17 | Akti_2008 | Akti 2008 | Akti2008 | Akti-2008 | Akt Inhibitor 17 )

产品货号. M16440 CAS No. 893422-47-4

一种有效的选择性 Akt1 和 Akt2 双重抑制剂,IC50 分别为 3.5 nM 和 42 nM。

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
5MG ¥2811 有现货
50MG ¥12069 有现货
100MG ¥16119 有现货
200MG 获取报价 有现货
500MG 获取报价 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    Akt1Akt2-IN-17
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    一种有效的选择性 Akt1 和 Akt2 双重抑制剂,IC50 分别为 3.5 nM 和 42 nM。
  • 产品描述
    A potent, selective dual Akt1 and Akt2 inhibitor with IC50 of 3.5 nM and 42 nM, respectively; shows selectivity for Akt1/2 over Akt3 (IC50=1900 nM), and highly selective over other members of the AGC family of kinases; inhibit the growth of A2780 tumors in vivo; shows good physical properties and PK profile.Lung Cancer Preclinical.
  • 体外实验
    Consistent with the allosteric mode of inhibition, Akt1/Akt2-IN-1 (Compound 17) is dependent on the PH-domain for Akt inhibition, is selective for Akt1/2 over Akt3 (IC50=1900 nM), and is highly selective over other members of the AGC family of kinases (>50 μM vs PKA, PKC, SGK). Akt1/Akt2-IN-1 has moderate activity in an hERG binding assay (IC50=5610 nM) and is a substrate for human P-glycoprotein.
  • 体内实验
    Akt1/Akt2-IN-1 (Compound 17) is well tolerated in at exposures that provide high levels of Akt1 and 2 inhibition in vivo. Akt1/Akt2-IN-1 has also been shown to inhibit the growth of A2780 tumors in vivo when used as monotherapy. Akt1/Akt2-IN-1 has potent inhibitory activity against Akt1 and 2 in vivo in a mouse lung and efficacy in a tumor xenograft model. Akt1/Akt2-IN-1 shows good pharmacokinetics in rat with a low clearance of 4.6 mL/min/kg and a half-life of 3.8 h. Due to the improved cell potency, physical properties, and rodent pharmacokinetics of Akt1/Akt2-IN-1, tolerability and Akt inhibition are assessed in mice. Using an acute dosing schedule (IP dosing of 50 mg/kg at times 0, 3, and 8 h), administration of Akt1/Akt2-IN-1 is well tolerated in mice and shows high levels of Akt inhibition in mouse lung.
  • 同义词
    Akt Inhibitor 17 | Akti_2008 | Akti 2008 | Akti2008 | Akti-2008 | Akt Inhibitor 17
  • 通路
    PI3K/Akt/mTOR signaling
  • 靶点
    Akt
  • 受体
    Akt
  • 研究领域
    Cancer
  • 适应症
    Lung Cancer

化学信息

  • CAS Number
    893422-47-4
  • 分子量
    539.6296
  • 分子式
    C33H29N7O
  • 纯度
    >98% (HPLC)
  • 溶解度
    DMSO: ≥ 35 mg/mL
  • SMILES
    O=C1C2=C(N=C(C3=CC=C(CN4CCC(C5=NNC(C6=NC=CC=C6)=N5)CC4)C=C3)C(C7=CC=CC=C7)=C2)C=CN1
  • 化学全称
    1,6-Naphthyridin-5(6H)-one, 3-phenyl-2-[4-[[4-[5-(2-pyridinyl)-1H-1,2,4-triazol-3-yl]-1-piperidinyl]methyl]phenyl]-

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1. Bilodeau MT, et al. Bioorg Med Chem Lett. 2008 Jun 1;18(11):3178-82. 2. Li Y, et al. Bioorg Med Chem Lett. 2009 Feb 1;19(3):834-6.
产品手册
关联产品
  • BAY-1125976

    一种有效且高度选择性的变构 AKT1/2 抑制剂,10 uM ATP 下的 IC50 为 5.2/18 nM。

  • Afuresertib

    一种有效的、选择性的 ATP 竞争性泛 AKT 抑制剂,对于 AKT1/2/3 的生化 IC50 为 0.08/2/2.6 nM。

  • TAS-117

    TAS-117 是一种高选择性、非 ATP 竞争性泛 Akt 抑制剂,对 Akt1/Akt2/Akt3 的 IC50 值分别为 4.8/1.6/44 nM。